Equities

Sigma Labs Inc

SGLB:QBB

Sigma Labs Inc

Actions
  • Price (USD)0.9601
  • Today's Change-0.0398 / -3.98%
  • Shares traded3.61k
  • 1 Year change-82.51%
  • Beta0.3379
Data delayed at least 15 minutes, as of Dec 09 2016 20:48 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Sigma Labs Inc grew revenues 125.03% from 548.72k to 1.23m while net income improved from a loss of 3.12m to a smaller loss of 1.70m.
Gross margin76.93%
Net profit margin-181.41%
Operating margin-184.03%
Return on assets-97.78%
Return on equity-108.38%
Return on investment-108.38%
More ▼

Cash flow in USDView more

In 2015, cash reserves at Sigma Labs Inc fell by 1.42m. Cash Flow from Financing was even, which indicates that this company's capital needs are balanced. In addition the company used 1.26m for operations while cash used for investing totalled 162.58k.
Cash flow per share-0.3276
Price/Cash flow per share--
Book value per share0.188
Tangible book value per share0.1525
More ▼

Balance sheet in USDView more

Sigma Labs Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio1.57
Quick ratio1.22
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.